Provided by Tiger Fintech (Singapore) Pte. Ltd.

Eli Lilly

776.44
+14.261.87%
Post-market: 776.19-0.2500-0.03%18:04 EDT
Volume:2.50M
Turnover:1.93B
Market Cap:735.86B
PE:63.18
High:778.29
Open:763.34
Low:762.50
Close:762.18
Loading ...

Eli Lilly (LLY) Enters Gene-Editing Space with Verve Therapeutics Acquisition

TIPRANKS
·
19 Jun

UBS Sticks to Its Buy Rating for Eli Lilly & Co (LLY)

TIPRANKS
·
18 Jun

Scholar Rock's Drug Helps Patients on Zepbound Preserve Muscle in Trial

Reuters
·
18 Jun

Hold Rating on Verve Therapeutics Acquisition by Eli Lilly: Fair Valuation with Low Competing Bid Potential

TIPRANKS
·
18 Jun

Health Rounds: Weight-loss surgery more effective than drugs in real world study

Reuters
·
18 Jun

Sector Update: Health Care Stocks Fall in Afternoon Trading

MT Newswires Live
·
18 Jun

Deals of the day-Mergers and acquisitions

Reuters
·
17 Jun

Eli Lilly Shares Down 1.8%

THOMSON REUTERS
·
17 Jun

Lilly to Buy Gene-Editing Partner Verve for up to $1.3 Billion in Cardiac Care Push

Reuters
·
17 Jun

Eli Lilly & Co (LLY) Receives a Buy from Citi

TIPRANKS
·
17 Jun

BRIEF-Lilly To Acquire Verve Therapeutics To Advance One-Time Treatments For People With High Cardiovascular Risk

Reuters
·
17 Jun

Lilly Shares Down 1.2% Premarket

THOMSON REUTERS
·
17 Jun

Eli Lilly to acquire Verve Therapeutics for $10.50 per share in cash

TIPRANKS
·
17 Jun

Eli Lilly: CVR Holders Would Be Entitled to GET Contingent Payment Upon First Patient Being Dosed With Verve-102 for Ascvd in U.S. Phase 3 Trial

THOMSON REUTERS
·
17 Jun

Eli Lilly - Transaction Is Not Subject to Any Financing Condition

THOMSON REUTERS
·
17 Jun

Eli Lilly - Proposed Deal for Purchase Price of $10.50 per Share in Cash

THOMSON REUTERS
·
17 Jun

Trump Says Pharma Tariffs Coming Very Soon

Reuters
·
17 Jun

Verve Therapeutics Soars 82% Following Report of $1.3B Eli Lilly Takeover Talks

Tiger Newspress
·
17 Jun

Verve Therapeutics Shares Jump 69.7% to $10.6 Premarket After FT Reports Eli Lilly Nears $1.3 Bln Deal for Co

THOMSON REUTERS
·
17 Jun

Verve Therapeutics Stock Soars 75% as Eli Lilly Nears $1.3 Billion Deal for the Gene-Editing Biotech

Reuters
·
17 Jun